FINANCE

Deutsche Bank sees 12% upside to S&P 500 through 2024-end

(Reuters) – Deutsche Bank said Monday it expects the S&P 500 to end next year 12% higher, as earnings growth should stay resilient even as

FINANCE

The Magnificent 7 Stocks Still Look Good. These 10 Smaller Stocks Could Be Even Better Buys.

Markets Tech Trader By Eric J. Savitz Updated Nov 27, 2023, 2:45 am EST / Original Nov 24, 2023, 1:00 am EST Share Reprints The

FINANCE

Oil Declines for Fourth Day on OPEC+ Intrigue and Risk-Off Tone

(Bloomberg) — Oil fell for a fourth day as traders looked ahead to this week’s delayed OPEC+ meeting and wider financial markets carried a risk-off

FINANCE

“If you like Bitcoin, buy Bitcoin”

CNBC Host Jim Cramer Is Now Bullish on Bitcoin: “If you like Bitcoin, buy Bitcoin” Jim Cramer, the host of CNBC’s Mad Money, has reversed

FINANCE

Gold atop 6-month peak on softer US dollar, bets on Fed pause

By Harshit Verma (Reuters) – Gold prices climbed a six-month peak on Monday, supported by a weaker U.S. dollar and on bets that the U.S.

FINANCE

Asian Stocks Fall as China Profit Growth Slows: Markets Wrap

(Bloomberg) — Asian stocks swung to a loss and US equity futures fell as slowing Chinese industrial profit growth sapped optimism after last week’s equity

FINANCE

Why Is Everyone So Unhappy at Work Right Now?

Listen to article (2 minutes) Americans, by many measures, are unhappier at work than they have been in years. Despite wage increases, more paid time

FINANCE

These Are The Best Robinhood Stocks To Buy Or Watch Now

Buying a stock is deceptively easy, but purchasing the right stock at the right time without a proven strategy is incredibly hard. So, what are

FINANCE

Green Stock Selloff Deepens as Tesla Sentiment Sours

(Bloomberg) — The selloff that’s ripped through green stocks looks set to continue into 2024, bringing a fourth consecutive year of losses, according to Bloomberg’s

FINANCE

Indian drug manufacturers benefit from Big Pharma interest beyond China

By Maggie Fick, Andrew Silver and Rishika Sadam LONDON/SHANGHAI/HYDERABAD (Reuters) – Drugmakers are seeking to limit their reliance on Chinese contractors who produce drugs used